Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-26

Clinical Trial Update: Progesterone Effect on Individuals Diagnoses With AD and PTSD. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating progesterone effects in individuals with alcohol dependence and PTSD; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Yale University | Conditions: Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-04-26